Atec Spine (ATEC) — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Total funding raised: $90M

Market Cap: $1.2BFounded: 2000HQ: Carlsbad, United States

Sector Ranking#13 in Regenerative Medicine

Overview

ATEC Spine's mission is to revolutionize the approach to spine surgery by moving beyond selling standalone implants to commercializing entire, optimized surgical methodologies, which it terms 'Approach Technologies.' The company has achieved significant commercial traction, reporting $764 million in total revenue for 2025, representing 25% year-over-year growth, and generating positive free cash flow. Its strategy centers on being an 'Organic Innovation Machine,' developing surgeon-inspired procedural solutions to drive clinical distinction and capture market share in the competitive spine device sector.

Spinal SurgeryOrthopedics

Technology Platform

An 'Organic Innovation Machine' focused on developing integrated procedural solutions and proprietary surgical approaches (Approach Technologies™), supported by intelligent implant designs and surgeon-centric development.

Funding History

2

Total raised:$90M

Series B$60MUndisclosedJun 15, 2020

Series A$30MUndisclosedJun 15, 2018

Opportunities

ATEC is positioned to capitalize on the large and growing global spine market by displacing competitors with its differentiated procedural solutions.

Key opportunities include expanding adoption of its proprietary Prone Transpsoas (PTP) approach, driving higher revenue per procedure through full solution kits, and executing on international market expansion.

Risk Factors

Key risks include the challenge of sustaining rapid surgeon adoption and commercial execution in a fiercely competitive market, potential pricing pressure from large incumbents and cost-conscious hospitals, and regulatory/legal exposures inherent to medical device companies.

Competitive Landscape

ATEC competes against large medtech conglomerates (Medtronic, Johnson & Johnson) and pure-play spine companies (Globus Medical, NuVasive, ZimVie). It differentiates through its surgeon-centric, procedural-focused 'Approach Technologies' model and proprietary techniques like PTP, rather than competing solely on individual product features.